Literature DB >> 10390454

Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.

B Ledergerber1, A Telenti, M Egger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10390454      PMCID： PMC28149          DOI： 10.1136/bmj.319.7201.23

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.

Authors:  M Egger; B Hirschel; P Francioli; P Sudre; M Wirz; M Flepp; M Rickenbach; R Malinverni; P Vernazza; M Battegay
Journal:  BMJ       Date:  1997-11-08

2.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

3.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

4.  Spectrum of AIDS-associated malignant disorders.

Authors:  J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

5.  The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics.

Authors:  B Ledergerber; J von Overbeck; M Egger; R Lüthy
Journal:  Soz Praventivmed       Date:  1994
  5 in total
  38 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 2.  Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.

Authors:  Aggrey S Semeere; Naftali Busakhala; Jeffrey N Martin
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

3.  Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy.

Authors:  Véronique Dufour; Jacques Cadranel; Marie Wislez; Armelle Lavole; Emmanuel Bergot; Antoine Parrot; Pierre Rufat; Charles Mayaud
Journal:  Lung       Date:  2004       Impact factor: 2.584

4.  The tumor virus landscape of AIDS-related lymphomas.

Authors:  Aaron Arvey; Akinyemi I Ojesina; Chandra Sekhar Pedamallu; Gianna Ballon; Joonil Jung; Fujiko Duke; Lorenzo Leoncini; Giulia De Falco; Eric Bressman; Wayne Tam; Amy Chadburn; Matthew Meyerson; Ethel Cesarman
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

Review 5.  Immunotherapy in Sarcoma: Future Horizons.

Authors:  Melissa Burgess; Vikram Gorantla; Kurt Weiss; Hussein Tawbi
Journal:  Curr Oncol Rep       Date:  2015-11       Impact factor: 5.075

6.  The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.

Authors:  Sharon Pipkin; Susan Scheer; Ijeoma Okeigwe; Sandra Schwarcz; David H Harris; Nancy A Hessol
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

Review 7.  AIDS related systemic non-Hodgkin's lymphoma.

Authors:  T Powles; G Matthews; M Bower
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

8.  Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.

Authors:  Jennifer R Moodley; Deborah Constant; Margaret Hoffman; Anna Salimo; Bruce Allan; Ed Rybicki; Inga Hitzeroth; Anna-Lise Williamson
Journal:  BMC Cancer       Date:  2009-08-07       Impact factor: 4.430

9.  Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.

Authors:  Sara Lodi; Marguerite Guiguet; Dominique Costagliola; Martin Fisher; Andrea de Luca; Kholoud Porter
Journal:  J Natl Cancer Inst       Date:  2010-05-04       Impact factor: 13.506

10.  Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.

Authors:  Julia Bohlius; Fabio Valeri; Mhairi Maskew; Hans Prozesky; Daniela Garone; Mazvita Sengayi; Matthew P Fox; Mary-Ann Davies; Matthias Egger
Journal:  Int J Cancer       Date:  2014-05-02       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.